Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554513 · ClinicalTrials.gov registry record · NA
Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02554513: Completed NA study, sponsored by VA Office of Research and Development.
NCT02554513 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02554513, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of the proposed research is to examine the effects of two treatment approaches on speech production involving speakers with chronic apraxia of speech (AOS) and aphasia. The planned investigation is designed to examine the acquisition, maintenance and generalization effects of each treatment. One approach, electropalatography (EPG) uses visual biofeedback in conjunction with articulatory-kinematic treatment and the other approach, sound production treatment (SPT) is one of the most systematically studied articulatory-kinematic treatments for AOS.
Interventions
- BEHAVIORAL SPT
- DEVICE EPG Tx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-11-02 |
| Est. Completion | 2019-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02554513
The ClinicalTrials.gov registry entry for NCT02554513 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SPT is the first listed.
NCT02554513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02554513 about?
NCT02554513 is a clinical study titled "Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT)". The purpose of the proposed research is to examine the effects of two treatment approaches on speech production involving speakers with chronic apraxia of speech (AOS) and aphasia. The planned investigation is designed to examine the acquisition, maintenance and generalization effects of each treatm...
What is the current status of trial NCT02554513?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2015-11-02. Estimated completion is 2019-06-28.
What interventions are being tested in trial NCT02554513?
The interventions under investigation include: SPT (BEHAVIORAL), EPG Tx (DEVICE).
Who is sponsoring clinical trial NCT02554513?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.